OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

(a) Applicants and authorisation holders
  • Name

  • Pioneer Overseas Corporation

    • Address

  • Avenue des Arts 44, B-1040 Brussels.

    • On behalf of Pioneer Hi-Bred International, Inc., 400 Locus Street, Suite 800, Des Moines, IA50309, United States of America

    and

    Name

  • Dow AgroSciences Europe Ltd

    • Address

  • European Development Centre, 3 Milton Park, Abingdon, Oxon OX14 4RN, United Kingdom.

    • On behalf of Mycogen Seeds c/o Dow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, IN 46268-1054, United States of America.

    F1(b) Designation and specification of the products
    1. (i)

      foods and food ingredients containing, consisting of, or produced from DAS-Ø15Ø7-1 maize;

    2. (ii)

      feed produced from DAS-Ø15Ø7-1 maize.

      The genetically modified DAS-Ø15Ø7-1 maize, as described in the application, is resistant to the European corn borer ( Ostrinia nubilalis ) and certain other lepidopteran pests and is tolerant to the herbicide glufosinate-ammonium. The genetically modified DAS-Ø15Ø7-1 maize contains the following DNA sequences in two cassettes:

      — cassette 1

    3. A synthetic version of the truncated cry 1F gene from Bacillus thuringiensis subsp. aizawai , which confers resistance to the European corn borer ( Ostrinia nubilalis ) and certain other lepidopteran pests, under the regulation of the ubiquitin promoter ubi ZM1(2) from Zea mays L. and the ORF25PolyA terminator from Agrobacterium tumefaciens pTi15955,

      4. — cassette 2

    4. A synthetic version of the pat gene from Streptomyces viridochromogenes strain Tü494, which confers tolerance to the herbicide glufosinate-ammonium, under the regulation of the 35S promoter and terminator sequences from Cauliflower Mosaic Virus .

    • (c) Labelling

    • No specific requirements other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003.

    • For the purpose of Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, the ‘name of organism’ shall be ‘maize’.

    • (d) Method for detection

    • Event specific real-time quantitative PCR based method for genetically modified maize DAS-Ø15Ø7-1.

    • Validated by the Community reference laboratory established pursuant to Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.it/detectionmethods/TC1507-WEB-Protocol-Validation.pdf

    • Reference Material: ERM®-BF418 accessible via the Joint Research Centre (JRC) of the European Commission, the Institute of Reference Materials and Measurements (IRMM) at http://www.irmm.jrc.be/html/reference_materials_catalogue/index.htm

    • (e) Unique identifier

  • DAS-Ø15Ø7-1

    • (f) Information required in accordance with Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity

  • Biosafety Clearing House, Record ID: see Decision 2006/197/EC.

    • (g) Conditions or restrictions on the placing on the market, use or handling of the products

  • Not required.

    • (h) Monitoring plan

  • Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC

    (Link: http://gmo-crl.jrc.it/detectionmethods/TC1507-WEB-Protocol-Validation.pdf)

    • (i) Post market monitoring requirements for the use of the food for human consumption

  • Not required.

    1. Division

    Annotations

    Textual amendments

    F1

    Substituted by Commission Decision of 17 June 2011 amending Decision 2006/197/EC as regards the renewal of the authorisation to place on the market existing feed produced from genetically modified maize line 1507 (DAS-Ø15Ø7-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2011) 4159) (Only the Dutch, English and French texts are authentic) (Text with EEA relevance) (2011/365/EU).